These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33055147)

  • 1. Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Fan P; Zhang Y; Lu YT; Yang KQ; Lu PP; Zhang QY; Luo F; Lin YH; Zhou XL; Tian T
    Heart; 2021 May; 107(10):836-841. PubMed ID: 33055147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging.
    Ivanov A; Dabiesingh DS; Bhumireddy GP; Mohamed A; Asfour A; Briggs WM; Ho J; Khan SA; Grossman A; Klem I; Sacchi TJ; Heitner JF
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28899950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
    Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
    Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Approach to Risk Stratification in Left Ventricular Non-Compaction Using A Combined Cardiac Imaging and Plasma Biomarker Approach.
    Ramchand J; Podugu P; Obuchowski N; Harb SC; Chetrit M; Milinovich A; Griffin B; Burrell LM; Wilson Tang WH; Kwon DH; Flamm SD
    J Am Heart Assoc; 2021 Apr; 10(8):e019209. PubMed ID: 33834849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.
    Zhou ZQ; He WC; Li X; Bai W; Huang W; Hou RL; Wang YN; Guo YK
    BMC Cardiovasc Disord; 2022 Feb; 22(1):25. PubMed ID: 35109817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
    Li X; Chen C; Gan F; Wang Y; Ding L; Hua W
    BMC Cardiovasc Disord; 2014 May; 14():67. PubMed ID: 24885051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
    Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
    Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of High-Sensitivity Cardiac Troponin T to Predict Long-Term Outcome in Patients with Hypertrophic Cardiomyopathy.
    Gommans DHF; Cramer GE; Fouraux MA; Heijmans S; Michels M; Timmermans J; Verheugt FWA; de Boer RA; Kofflard MJM; Brouwer MA
    Am J Cardiol; 2021 Aug; 152():120-124. PubMed ID: 34130823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators.
    Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Kambouraki DC; Arfanakis DA; Vardas PE
    Chest; 2005 Oct; 128(4):2604-10. PubMed ID: 16236931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
    Wu KC; Gerstenblith G; Guallar E; Marine JE; Dalal D; Cheng A; Marbán E; Lima JA; Tomaselli GF; Weiss RG
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):178-86. PubMed ID: 22267750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting].
    Lu YF; Qi HW; Tang CZ; Wu MY; Wang Y; Zhao FH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):667-70. PubMed ID: 17996134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy.
    Stolfo D; Ceschia N; Zecchin M; De Luca A; Gobbo M; Barbati G; Gigli M; Masè M; Pinamonti B; Pivetta A; Merlo M; Sinagra G
    Am J Cardiol; 2018 Jun; 121(12):1601-1609. PubMed ID: 29678335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma big endothelin-1 is an effective predictor for ventricular arrythmias and end-stage events in primary prevention implantable cardioverter- defibrillator indication patients.
    Li XY; Zhao S; Fan XH; Chen KP; Hua W; Liu ZM; Xue XD; Zhou B; Zhang S
    J Geriatr Cardiol; 2020 Jul; 17(7):427-433. PubMed ID: 32863825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
    Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of incessant ventricular tachyarrhythmias on serum endothelin and big-endothelin levels.
    Szûcs A; Róka A; Soós P; Szilágyi S; Vágó H; Keltai K; Csaba Dezsi A; Gellér L; Merkely B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S402-6. PubMed ID: 15838333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.
    Zegard A; Okafor O; de Bono J; Kalla M; Lencioni M; Marshall H; Hudsmith L; Qiu T; Steeds R; Stegemann B; Leyva F
    J Am Coll Cardiol; 2021 Jan; 77(1):29-41. PubMed ID: 33413938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.